Apollo Hospitals Enterprise logo

Apollo Hospitals Enterprise share news, announcements and annual reports

NSE: APOLLOHOSPBSE: 508869Healthcare ServicesLarge Cap

Apollo Hospitals Enterprise Limited · Face value ₹5 · Listed Mar 1983 on BSE, Jan 1996 on NSE
Last close ₹8,448.00up ₹248.00 (3.02%)BSE ₹8,400.00

Share price at the NSE close on 30 Oct 2026. Previous close ₹8,200.00.

30 Oct: open ₹8,195.00, high ₹8,448.00, low ₹8,176.00

52-week range of traded prices to 30 Oct 2026
₹6,696.50Low, 23 Jan 2026₹9,070.50High, 23 Sep 2026
Market cap
₹1,21,469 Cr97th largest listed
P/E
58.13
P/B
12.81
Dividend yield
0.24%
ROE
23.6%
ROCE
19.9%
Debt to equity
0.57
Volume, NSE
3,72,15658.2% delivered

Apollo Hospitals Enterprise share news and announcements

863 announcements, routine notices left out, newest first. Page 17 of 18.

  1. Apr 2009

    • 17 Apr · Board meeting

      Meeting of the Committee is scheduled to be held on April 18, 2009, to approve issue and allot 1,549,157 equity shares of Rs. 10/- each at a price of Rs. 497.69 per share to Dr. Prathap C Reddy, promoter of the Company upon conversion of 1,549,157 share warrants alloted to him on October 19, 2007.
    • 9 Apr · Results

      We are in the process of finalization of auditing the accounts for the year ended 31st March, 2009 and the audited results will be published on or before 30th June, 2009.
  2. Feb 2009

    • 17 Feb · Disclosure

      Complete disclosure of statement (revised) with the last page in terms of Regulation 8A (4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements) For more details click here.
    • 16 Feb · Disclosure

      Disclosure pursuant to Regulation 8A(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997 containing details of shares pledged by the promoters/promoter group. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
  3. Jan 2009

    • 31 Jan · Updates

      Quintiles,USA, a global leader in pharmaceutical services, in association with Apollo Hospitals, India, the largest health care service provider in India, will be setting up a phase I Clinical trial research facility in Hyderabad at an estimated cost of USD 6 million, through a separate Joint Venture Company to be formed for this purpose. Apollo Hospitals Enterprise Limited ( AHEL ) and Quintiles Mauritius Holding Inc., ( Quintiles ) have entered into a shareholders Agreement in this regard on January 27, 2009 at Hyderabad. Quintiles and AHEL will be funding the project cost in the ratio of 60-40 respectively through a combination of and /or equity.
    • 30 Jan · Management

      Board of Directors of the Company at its meeting held on January 30, 2009 has taken the following decisions: (1) Approved the appointment of Mr. Habibullah Badsha as a director of the Company with effect from January 30, 2009 in the casual vacancy created earlier. (2) Approved the appointment of Mr. Michael Fernandes as an Alternate director to Mr. Khairil Anuar Abdullah, director of the Company. (3) Authorizing Dr. Pratap C Reddy, Chairman to sign the Shareholders/Joint Venture Agreement with MARG Limited, Chennai, a leading Infrastructure and Real Estate development company, for implementing multi level car parking project near Apollo Hospitals, Greams Road, Chennai.
    • 30 Jan · Results

      Standalone Results for the quarter ended on 31-DEC-2008 as follows: Net Sales of Rs. 37300 lacs for quarter ending on 31-DEC-2008 against Rs. 28910 lacs for the quarter ending on 31-DEC-2007. Net Profit / (Loss) of Rs. 2953 lacs for the quarter ending on 31-DEC-2008 against Rs. 2630 lacs for the quarter ending on 31-DEC-2007.
    • 15 Jan · Board meeting

      Inter alia, to consider, approve and take on record unaudited financial results of the Company for the quarter/nine months ended December 31, 2008.
  4. Dec 2008

    • 5 Dec · Management

      Mr. Habibullah Badsha resigned from the directorship of the Company with effect from December 01, 2008 due to pressing professional commitments.
  5. Oct 2008

    • 30 Oct · Results

      Standalone Results for the half year ended on 30-SEP-2008 as follows: Net Sales of Rs. 69390 lacs for half year ending on 30-SEP-2008 against Rs. 53070 lacs for the half year ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 5940 lacs for the half year ending on 30-SEP-2008 against Rs. 5360 lacs for the half year ending on 30-SEP-2007.
    • 30 Oct · Results

      Standalone Results for the quarter ended on 30-SEP-2008 as follows: Net Sales of Rs. 36483 lacs for quarter ending on 30-SEP-2008 against Rs. 28090 lacs for the quarter ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 3013 lacs for the quarter ending on 30-SEP-2008 against Rs. 2360 lacs for the quarter ending on 30-SEP-2007.
    • 30 Oct · Updates

      Board of Directors at it meeting held on October 30, 2008 has taken the following decisions: (1) Dropped the proposal of sub-division of each equity share of Rs.10/- each into 10 (Ten) equity shares of Re.1/- each.
    • 17 Oct · Board meeting

      Inter alia, to consider, approve the following:- (1) unaudited financial results of the Company for the quarter/ half year ended September 30, 2008. (2) Sub-division (Split) of equity shares of the Company and other matters connected therewith.
  6. Sep 2008

    • 2 Sep · Meeting

      Proceedings of the Annual General Meeting of the Shareholders of the Company held on August 28, 2008. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
  7. Aug 2008

    • 22 Aug · Allotment of Equity Shares

      Committee of Board of Directors at its meeting held today approved the allotment of 1,550,000 equity shares of face value of Rs. 10/- each at a price of Rs. 442.55 per share to Ms. Sangita Reddy, one of the promoters of the Company. Kindly note that consequent to the above allotment, the paid up share capital of the company has been increased to Rs. 602,357,020/- (consisting of 60,235,702 equity shares of Rs 10/- each ) from Rs. 586,857,020/- (consisting of 58,685,702 equity shares of Rs.10/- each).
    • 20 Aug · Board meeting

      Meeting of the Committee is scheduled to be held on August 22, 2008, to approve, issue and allot 1,550,000 equity shares of Rs. 10/- each at a price of Rs. 442.55 per share to Ms. Sangita Reddy, one of the promoters of the company upon conversion of 1,550,000 share warrants allotted to her on February 23, 2007.
  8. Jul 2008

    • 17 Jul · Board meeting

      Meeting on 31 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”
  9. Jun 2008

    • 24 Jun · Board meeting

      Board of Directors at its meeting held on June 24, 2008 has taken the following decisions: Approved in-principle for issue of :- a) Warrants not exceeding 58,68,000 convertible into equity shares to the Promoters/Promoter group. b) 758,000 equity shares/warrants convertible into equity shares to Apax Mauritius FDI One Limited. c) Authorised the committee to decide on the actual No. of warrants and equity shares and the timing for issue of the same in accordance with the then existing SEBI guidelines and other applicable regulations.
    • 24 Jun · Meeting

      Board of Directors at its meeting held on June 24, 2008 has taken the following decisions: 1) Recommended a dividend of Rs. 6.00 per share (60%) on the equity capital of the Company. 2) The Register of Members and Share Transfer Registers shall remain closed from August 13, 2008 to August 28, 2008 (both days inclusive). 3) The Annual General Meeting of the Company is scheduled to be held on August 28, 2008.
    • 24 Jun · Results

      Standalone Results for the quarter ended on 31-MAR-2008 as follows: Net Sales of Rs. 30400 lacs for quarter ending on 31-MAR-2008 against Rs. 23340 lacs for the quarter ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 2190 lacs for the quarter ending on 31-MAR-2008 against Rs. 1460 lacs for the quarter ending on 31-MAR-2007.
    • 24 Jun · Results

      Standalone Results for the year ended on 31-MAR-2008 as follows: Net Sales of Rs. 112380 lacs for year ending on 31-MAR-2008 against Rs. 89100 lacs for the year ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 10180 lacs for the year ending on 31-MAR-2008 against Rs. 10010 lacs for the year ending on 31-MAR-2007.
    • 24 Jun · Results

      Consolidated Results for the year ended on 31-MAR-2008 as follows: Net Sales of Rs. 121470 lacs for year ending on 31-MAR-2008 against Rs. 94950 lacs for the year ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 7710 lacs for the year ending on 31-MAR-2008 against Rs. 9540 lacs for the year ending on 31-MAR-2007.
    • 9 Jun · Board meeting

      To consider inter alia:- (i) the Audited Financial Results of the Company for the year ended March 31, 2008. (ii) the Audited Consolidated Financial Results of the Company and its subsidiaries, Joint Ventures and Associate Companies for the year ended March 31, 2008. (iii) to recommend a dividend, if any, for the financial year ended March 31, 2008.
  10. Apr 2008

    • 4 Apr · Results

      We are in the process of finalization of auditing the accounts for the year ended 31st March 2008 and the audited results will be published on or before 30th June 2008.
  11. Jan 2008

    • 24 Jan · Results

      Standalone Results for the quarter ended on 31-DEC-2007 as follows: Net Sales of Rs. 28910 lacs for quarter ending on 31-DEC-2007 against Rs. 23280 lacs for the quarter ending on 31-DEC-2006. Net Profit / (Loss) of Rs. 2630 lacs for the quarter ending on 31-DEC-2007 against Rs. 1790 lacs for the quarter ending on 31-DEC-2006.
    • 9 Jan · Board meeting

      Inter alia, to consider, approve and take on record unaudited financial results of the Company for the quarter/nine months ended December 31, 2007.
    • 1 Jan · Meeting

      Proceedings of Extraordinary General Meeting of the Company held on December 27, 2007.A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
  12. Dec 2007

    • 6 Dec · Meeting

      Notice convening an Extraordinary General Meeting of the Company scheduled to be held on December 27, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
  13. Nov 2007

    • 20 Nov · Meeting

      Vide its letter dated November 19, 2007, that: "The Board of Directors at its meeting held today approved the following:- (i) Appointment of Mr. Neeraj Bharadwaj (Nominee of Apax Mauritius FDI One Limited) as an Additional Director with effect from 19th November 2007. (ii) Amendment of Articles of Association of the Company. (iii) Convene EGM on 27th December 2007 to obtain members approval for amending the Articles of Association of the Company".
  14. Oct 2007

    • 27 Oct · Allotment of Equity Shares

      Vide its letter dated October 26, 2007 that "The Committee of Board of Directors at its meeting held today approved the allotment of 7,047,119 equity shares of face value of Rs.10/- each at a price of Rs.605.07 per share to Apax Mauritius FDI One Limited".
    • 25 Oct · Allotment of Equity Shares

      The Meeting of the Share Allotment Committee is scheduled to be held on 26th October 2007 to approve, issue and allot 7,047,119 equity shares of Rs.10/- each at a price of Rs. 605.07 per share to Apax Mauritius FDI One Limited
    • 23 Oct · Results

      Standalone Results for the half year ended on 30-SEP-2007 as follows: Net Sales of Rs. 53070 lacs for half year ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 5360 lacs for the half year ending on 30-SEP-2007.
    • 23 Oct · Results

      Standalone Results for the quarter ended on 30-SEP-2007 as follows: Net Sales of Rs. 28090 lacs for quarter ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 2360 lacs for the quarter ending on 30-SEP-2007.
    • 19 Oct · Allotment of Warrants

      Vide is letter dated October 19, 2007 "The Committee of Board of Directors at its meeting held today approved the allotment of 1,549,157 Equity Share Warrants to Dr. Prathap C Reddy, with each warrant convertible into one Equity share of the Company of nominal value of Rs.10/- each at a price of Rs.497.69 which includes a premium of Rs. 487.69 per share. The warrants shall be convertible into equity shares at any time within 18 months from the date of allotment i.e., 18th April 2009 ."
    • 17 Oct · Allotment of Warrants

      The Committee is meeting on Friday, 19th October 2007 to approve the allotment of 1,549,157 warrants to Dr. Prathap C Reddy pursuant to the special resolution approved by the members at the EGM held on 06th October 2007.
    • 12 Oct · Board meeting

      Meeting on 23 Oct 2007: “Unaudited Results for Qtr & Half year ended Sep 30, 2007”
    • 10 Oct · Meeting

      Proceedings of the Extraordinary General Meeting of the Company held on October 06, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 8 Oct · Meeting

      Vide their letter dated October 06, 2007, that: "The members of the company approved the following special resolutions at the Extraordinary General Meeting held today, (i) To issue up to 1,549,157 Warrants on a preferential basis to Dr. Prathap C Reddy, one of the promoters of the Company with each Warrant convertible into one equity share of the company of nominal value of Rs.10/- each at a price of Rs.497.69 which includes a premium of Rs.487.69 per share, which price is not less than the price calculated in accordance with Securities and Exchange Board of India (Disclosure and Investor Protection) Guidelines, 2000. (ii) To issue up to 7,047,119 equity shares of the company of nominal value of Rs.10/- each at a price of Rs.605.07 per Share which includes a premium of Rs.595.07 per Share, which price is not less than the price calculated in accordance with the SEBI (DIP) Guidelines, on a preferential basis to any or all of the following entities, (i) Apax Mauritius (FVCI) Ltd., and (ii) Apax Mauritius FDI One Ltd, companies incorporated under the laws of Mauritius".
  15. Sep 2007

    • 14 Sep · Meeting

      Notice convening an Extraordinary General Meeting of the Company scheduled to be held on October 06, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 4 Sep · Meeting

      The Extraordinary General Meeting of the Company is scheduled to be held on Saturday 6th October 2007 instead of 5th October 2007 to obtain members approval for the proposals mentioned in the letter dated 31st August 2007.
  16. Aug 2007

    • 31 Aug · Meeting

      The Board of Directors of Apollo Hospitals Enterprise Limited ("AHEL") has at its meeting held on Friday, August 31, 2007, recommended the following :- (i) issue of up to 1,549,157 (3% of existing capital of the company) warrants convertible into equity shares to the promoters/promoter group at a price not less than the price calculated in accordance with SEBI (Disclosure and Investor Protection) Guidelines for preferential issue. (ii) issue of up to 7,047,119 equity shares of Rs. 10/- each on a preferential basis to funds advised by Apax Partners ("Apax") at a price of Rs.605.07 per equity share. Apax will invest up to Rs.4264 million (approx.US$104 million) in AHEL. The investment is in accordance with Chapter XIII of the Securities and Exchange Board of India (Disclosure and Investor Protection) Guidelines, 2000 and is subject to shareholder approvals, necessary regulatory approvals and final closing condition. The Extraordinary General Meeting of the Company is to be convened on 5th October 2007 for obtaining members approval for the above said issues. The Company plans to use the funds raised through preferential allotment for meeting its future growth plans of setting up new hospitals and expanding other healthcare facilities
    • 28 Aug · Meeting

      Proceedings of Annual General Meeting of the Company held on August 24, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
    • 1 Aug · Business

      Apollo Hospitals Enterprise Limited (AHEL) have been in negotiation with British American Investment Co (Mauritius) Ltd (BAI) for associating in a Joint Venture for setting up a multi speciality hospital on a state land provided by Government of Mauritius. The Joint Venture Company, British American Hospitals Enterprise Limited (BAHEL) has been formed and Joint Venture Agreement between AHEL, BAI, BAI Medical Centres Limited (BMCL), subsidiary of BAI and the said BAHEL, has been entered into on 31st July 2007 in this regard. AHEL will be holding 26% of the total equity capital of Joint Venture Company and the balance 74% will be held by BMCL
  17. Jul 2007

    • 23 Jul · Results

      Standalone Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 24980 lacs for quarter ending on 30-JUN-2007 against Rs. 20410 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 3000 lacs for the quarter ending on 30-JUN-2007 against Rs. 1730 lacs for the quarter ending on 30-JUN-2006.
    • 11 Jul · Board meeting

      Meeting on 23 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007”
  18. Jun 2007

    • 26 Jun · Meeting

      Board of Directors of the Company at its meeting held on June 26, 2007 has recommended a final dividend of Rs.2/- per share (20%) on the equity capital of the Company in addition to an interim dividend of Rs.3/- per share (30%) declared and paid during the year. Further the Company has informed the Exchange that the Register of Member and Share Transfer Registers shall remain closed from August 11, 2007 to August 24, 2007(both days inclusive) and the Annual General Meeting of the Company is Scheduled to be held on August 24, 2007.
    • 26 Jun · Results

      Standalone Results for the year ended on 31-MAR-2007 as follows: Net Sales of Rs. 89100 lacs for year ending on 31-MAR-2007 against Rs. 70780 lacs for the year ending on 31-MAR-2006. Net Profit / (Loss) of Rs. 10010 lacs for the year ending on 31-MAR-2007 against Rs. 6020 lacs for the year ending on 31-MAR-2006.
    • 26 Jun · Results

      Consolidated Results for the year ended on 31-MAR-2007 as follows: Net Sales of Rs. 94950 lacs for year ending on 31-MAR-2007 against Rs. 76960 lacs for the year ending on 31-MAR-2006. Net Profit / (Loss) of Rs. 9540 lacs for the year ending on 31-MAR-2007 against Rs. 5200 lacs for the year ending on 31-MAR-2006.
    • 26 Jun · Results

      Standalone Results for the quarter ended on 31-MAR-2007 as follows: Net Sales of Rs. 23340 lacs for quarter ending on 31-MAR-2007 against Rs. 19200 lacs for the quarter ending on 31-MAR-2006. Net Profit / (Loss) of Rs. 1460 lacs for the quarter ending on 31-MAR-2007 against Rs. 1240 lacs for the quarter ending on 31-MAR-2006.
    • 15 Jun · E-mail ID for Investor Complaints

      " The company has designated following dedicated email id for the purpose of registering complaints by investors and the same will be displayed in the company's website www.apollohospitals.com. Email ID : investor.relations@apollohospitals.com